Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
2-[(3S,6S,9S,12S,15S,18S,21S,24S,27S,30S,33S,39R,42S)-39-[(2-amino-2-oxo-ethyl)carbamoyl]-33-benzyl-3-(3-guanidinopropyl)-21,24-bis[(1R)-1-hydroxyethyl]-27-(hydroxymethyl)-30-isopropyl-9,10,15,16-tetramethyl-2,5,8,11,14,17,20,23,26,29,32,35,41-tridecaoxo-12,18-bis[(4-phenylphenyl)methyl]-37-thia-1,4,7,10,13,16,19,22,25,28,31,34,40-tridecazabicyclo[40.3.0]pentatetracontan-6-yl]acetic acid
ID: ALA5271747
Chembl Id: CHEMBL5271747
Max Phase: Preclinical
Molecular Formula: C85H112N18O20S
Molecular Weight: 1738.00
Associated Items: